Navigation Links
Bryan, Garnier & Co Announces the Successful $275m IPO for Galapagos NV, the Largest Nasdaq IPO of European Biotech

LONDON, May 14, 2015 /PRNewswire/ --

Bryan, Garnier & Co, the pan-European investment bank for growth companies, announces the successful $275 million Nasdaq IPO for Galapagos NV, a major European clinical-stage biotechnology company. Bryan, Garnier & Co is the only European investment bank in the IPO syndicate. The Galapagos IPO on Nasdaq confirms the strong momentum of the European healthcare sector.


Galapagos NV (Euronext: GLPG) announced today the pricing of its global offering totaling $275 million gross proceeds, initially filed for $150 million. The new shares were placed in a concurrent public offering in the US through ADSs at a price of $42.05 and private placement in Europe at a price of €37 per share. It is the largest Nasdaq IPO of a European biotech and one of three largest biotech IPO ever in Europe or in the US.

Bryan, Garnier & Co acted as co-manager and sole European investment bank, alongside Morgan Stanley, Credit Suisse, Cowen and Company and Nomura.  

Bryan Garnier & Co keeps on leading the financing of the European healthcare companies, in Europe and in the US:  

  • Bryan, Garnier & Co was the only European investment bank involved in the top 5 IPOs of European healthcare companies on Nasdaq i.e. Galapagos (Belgium), DBV Technology (France), Forward Pharma (Denmark), Cellectis (France), Adaptimune (UK), as well as in the IPO of LDR Holding (US/France).
  • Bryan, Garnier & Co confirms its leading position in the financing of the European emerging biopharma industry, through private equity placements, PIPEs, and public offerings, on both the European and the American equity capital markets (LSE, AIM, Euronext, Alternext, and Nasdaq OMX).
  • Cumulated placements managed by Bryan, Garnier & Co in healthcare exceeded 1b€ over the past 24 months including 3 Nasdaq IPOs (Galapagos, DBV Technologies and LDR Holding).

For more information, please contact Anna Emelianenko ( | +33-1-56-68-75-00) or Daiana Hirte ( | +33-1-56-26-72-00).

About Galapagos:

About Bryan, Garnier & Co:

SOURCE Bryan, Garnier & Co
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
2. S&D Marketing Advertising Awarded WBENC Certification
3. P&P Optica Invited to Cambridge Innovation Centre for the Canadian Technology Accelerator Program, One of Eight Canadian Life Science Companies Chosen to Participate
4. Updated Stock of Sapphire & Glass Ball Lenses Now Includes Fused Silica
5. Regeneron Pharmaceuticals’ Industrial Operations & Product Supply Site Receives International Recognition for Operational Excellence
6. The BioVoyage Institute Now Offering Hands-On Training Programs For Biotechnology Products & Applications
7. DuPont Joins Israel’s Office of the Chief Scientist Global Enterprise R&D Cooperation Framework
8. DuPont Tate & Lyle Bio Products Announces Novel Application for Zemea® Propanediol
9. Smith & Nephew hosts thought-leading surgeons, showcases new technology at American Academy of Orthopaedic Surgeons annual meeting
10. Serial Start-up Entrepreneur, Rudy Mazzocchi, once again Nominated for the Ernst & Young Entrepreneur of the Year Award.
11. Smith & Nephew releases new Modular Rail System in collaboration with Dr. Dror Paley
Post Your Comments:
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):